Cite

HARVARD Citation

    Bafadhel, M. et al. (2021). A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial. European respiratory journal. 58 (3), p. . [Online]. 
  
Back to record